Haleon plc (HLN.L)
LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 01:19PM BST. Market open.
| Previous Close | 332.80 |
| Open | 332.90 |
| Bid | 334.10 x N/A |
| Ask | 334.20 x N/A |
| Day's Range | 332.80 - 335.90 |
| 52 Week Range | 306.80 - 355.00 |
| Volume | |
| Avg. Volume | 26,303,724 |
| Market Cap | 30.511B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 30.37 |
| EPS (TTM) | 0.11 |
| Earnings Date | Feb 29, 2024 |
| Forward Dividend & Yield | 0.06 (1.80%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | 363.53 |
Simply Wall St.Haleon plc (LON:HLN) Shares Could Be 24% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
ZacksPharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
ZacksGSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
© 2024 Yahoo. All rights reserved.